Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers

Atsuhiko Toyama, Atsushi Suzuki, Takashi Shimada, Chikage Aoki, Yutaka Aoki, Yukari Umino, Yusuke Nakamura, Daisuke Aoki, Taka Aki Sato

研究成果: Article

30 引用 (Scopus)

抄録

Numerous studies have suggested that the different histological subtypes of ovarian carcinoma (i.e. clear cell, endometrioid, mucinous, and serous) have distinct clinical histories and characteristics; however, most studies that have aimed to determine biomarker have not performed comprehensive analyses based on subtype specificity. In the present study, we performed two-dimensional gel electrophoresis-based differential proteomic analysis of the different histological subtypes of ovarian carcinoma using tissue specimens from 39 patients. Seventy-seven protein spots (55 unique proteins) were found to be up- or downregulated in a subtype-specific manner. The most significant difference was observed for: (i) annexin-A4 (ANXA4) and phosphoserine aminotransferase (PSAT1), which are expressed strongly in clear cell carcinoma; (ii) cellular retinoic acid-binding protein 2 (CRABP2), which is expressed specifically in serous carcinoma; and (iii) serpin B5 (SPB5), which is upregulated in mucinous carcinoma. Validation of these candidates by western blotting using a 34 additional test sample set resulted in an expression pattern that was consistent with the screening and revealed that differential expression was independent of cancer stage or tumor grade within each subtype. Thus, the present study reinforces the notion that ovarian cancer subtypes can be clearly delineated on a molecular basis into four histopathological groups, and we propose that ANXA4, PSAT1, CRABP2, and SPB5 are candidate subtype-specific biomarkers that can help define the basis of tumor histology at a molecular level.

元の言語English
ページ(範囲)747-755
ページ数9
ジャーナルCancer Science
103
発行部数4
DOI
出版物ステータスPublished - 2012 4

Fingerprint

phosphoserine aminotransferase
Annexin A4
Retinoic Acid Receptors
Proteomics
Ovarian Neoplasms
Histology
Biomarkers
Carcinoma
Serpins
Mucinous Adenocarcinoma
Neoplasms
Electrophoresis, Gel, Two-Dimensional
Proteins
Down-Regulation
Western Blotting
serpin-2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

これを引用

Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. / Toyama, Atsuhiko; Suzuki, Atsushi; Shimada, Takashi; Aoki, Chikage; Aoki, Yutaka; Umino, Yukari; Nakamura, Yusuke; Aoki, Daisuke; Sato, Taka Aki.

:: Cancer Science, 巻 103, 番号 4, 04.2012, p. 747-755.

研究成果: Article

Toyama, Atsuhiko ; Suzuki, Atsushi ; Shimada, Takashi ; Aoki, Chikage ; Aoki, Yutaka ; Umino, Yukari ; Nakamura, Yusuke ; Aoki, Daisuke ; Sato, Taka Aki. / Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. :: Cancer Science. 2012 ; 巻 103, 番号 4. pp. 747-755.
@article{8a16b6247f6645c389277132a660058c,
title = "Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers",
abstract = "Numerous studies have suggested that the different histological subtypes of ovarian carcinoma (i.e. clear cell, endometrioid, mucinous, and serous) have distinct clinical histories and characteristics; however, most studies that have aimed to determine biomarker have not performed comprehensive analyses based on subtype specificity. In the present study, we performed two-dimensional gel electrophoresis-based differential proteomic analysis of the different histological subtypes of ovarian carcinoma using tissue specimens from 39 patients. Seventy-seven protein spots (55 unique proteins) were found to be up- or downregulated in a subtype-specific manner. The most significant difference was observed for: (i) annexin-A4 (ANXA4) and phosphoserine aminotransferase (PSAT1), which are expressed strongly in clear cell carcinoma; (ii) cellular retinoic acid-binding protein 2 (CRABP2), which is expressed specifically in serous carcinoma; and (iii) serpin B5 (SPB5), which is upregulated in mucinous carcinoma. Validation of these candidates by western blotting using a 34 additional test sample set resulted in an expression pattern that was consistent with the screening and revealed that differential expression was independent of cancer stage or tumor grade within each subtype. Thus, the present study reinforces the notion that ovarian cancer subtypes can be clearly delineated on a molecular basis into four histopathological groups, and we propose that ANXA4, PSAT1, CRABP2, and SPB5 are candidate subtype-specific biomarkers that can help define the basis of tumor histology at a molecular level.",
author = "Atsuhiko Toyama and Atsushi Suzuki and Takashi Shimada and Chikage Aoki and Yutaka Aoki and Yukari Umino and Yusuke Nakamura and Daisuke Aoki and Sato, {Taka Aki}",
year = "2012",
month = "4",
doi = "10.1111/j.1349-7006.2012.02224.x",
language = "English",
volume = "103",
pages = "747--755",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers

AU - Toyama, Atsuhiko

AU - Suzuki, Atsushi

AU - Shimada, Takashi

AU - Aoki, Chikage

AU - Aoki, Yutaka

AU - Umino, Yukari

AU - Nakamura, Yusuke

AU - Aoki, Daisuke

AU - Sato, Taka Aki

PY - 2012/4

Y1 - 2012/4

N2 - Numerous studies have suggested that the different histological subtypes of ovarian carcinoma (i.e. clear cell, endometrioid, mucinous, and serous) have distinct clinical histories and characteristics; however, most studies that have aimed to determine biomarker have not performed comprehensive analyses based on subtype specificity. In the present study, we performed two-dimensional gel electrophoresis-based differential proteomic analysis of the different histological subtypes of ovarian carcinoma using tissue specimens from 39 patients. Seventy-seven protein spots (55 unique proteins) were found to be up- or downregulated in a subtype-specific manner. The most significant difference was observed for: (i) annexin-A4 (ANXA4) and phosphoserine aminotransferase (PSAT1), which are expressed strongly in clear cell carcinoma; (ii) cellular retinoic acid-binding protein 2 (CRABP2), which is expressed specifically in serous carcinoma; and (iii) serpin B5 (SPB5), which is upregulated in mucinous carcinoma. Validation of these candidates by western blotting using a 34 additional test sample set resulted in an expression pattern that was consistent with the screening and revealed that differential expression was independent of cancer stage or tumor grade within each subtype. Thus, the present study reinforces the notion that ovarian cancer subtypes can be clearly delineated on a molecular basis into four histopathological groups, and we propose that ANXA4, PSAT1, CRABP2, and SPB5 are candidate subtype-specific biomarkers that can help define the basis of tumor histology at a molecular level.

AB - Numerous studies have suggested that the different histological subtypes of ovarian carcinoma (i.e. clear cell, endometrioid, mucinous, and serous) have distinct clinical histories and characteristics; however, most studies that have aimed to determine biomarker have not performed comprehensive analyses based on subtype specificity. In the present study, we performed two-dimensional gel electrophoresis-based differential proteomic analysis of the different histological subtypes of ovarian carcinoma using tissue specimens from 39 patients. Seventy-seven protein spots (55 unique proteins) were found to be up- or downregulated in a subtype-specific manner. The most significant difference was observed for: (i) annexin-A4 (ANXA4) and phosphoserine aminotransferase (PSAT1), which are expressed strongly in clear cell carcinoma; (ii) cellular retinoic acid-binding protein 2 (CRABP2), which is expressed specifically in serous carcinoma; and (iii) serpin B5 (SPB5), which is upregulated in mucinous carcinoma. Validation of these candidates by western blotting using a 34 additional test sample set resulted in an expression pattern that was consistent with the screening and revealed that differential expression was independent of cancer stage or tumor grade within each subtype. Thus, the present study reinforces the notion that ovarian cancer subtypes can be clearly delineated on a molecular basis into four histopathological groups, and we propose that ANXA4, PSAT1, CRABP2, and SPB5 are candidate subtype-specific biomarkers that can help define the basis of tumor histology at a molecular level.

UR - http://www.scopus.com/inward/record.url?scp=84862829101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862829101&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2012.02224.x

DO - 10.1111/j.1349-7006.2012.02224.x

M3 - Article

C2 - 22321069

AN - SCOPUS:84862829101

VL - 103

SP - 747

EP - 755

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 4

ER -